Biocompatible solute

The utilization of new biocompatible solutions in APD with alternative osmotic agents, nutritional integration, reduced sodium content, and alternative buffers is attractive, particularly because of the higher fluid volumes and peritoneal contact with APD (Dejaegher 1997, Douma 1998). 

The described bioaffinity separations demonstrate that polyacrylamide spacers aid the selective binding of highly complex and delicate biomacromolecules and their associates. Moreover, these solutes remain biologically active after desorption probably due to the high inertness and flexibility of the surrounding polymer chains fixed on the solid support. The unbound parts of serum usually show no loss of the activities of their constituents. Thus we evaluate the surface of inorganic supports coated with chemisorbed iV-hydroxyethyl polyacrylamide and its derivatives as being biocompatible. 

Causton, B. E. (1982). Primers and mineralizing solutions. In Smith, D. C. Williams, D. F. (eds.) Biocompatibility of Dental Materials. Volume II. Biocompatibility of Preventive Dental Materials and Bonding Agents, Chapter 7. Boca Raton, Florida CRC Press Inc. 

As mentioned previously (and discussed in detail in Sec. IX), contact lens products have specific guidelines that focus on compatibility with the contact lens and biocompatibility with the cornea and conjunctiva [75], These solutions are viewed as new medical devices and require testing with the contact lenses with which they are to be used. Tests include a 21-day ocular study in rabbits and employ the appropriate types of contact lenses with which they are to be used and may include the other solutions that might be used with the lens. Additional tests to evaluate cytotoxicity potential, acute toxicity, sensitization potential (allergenicity), and risks specific to the preparation are also required [75-77], These tests are sufficient to meet requirements in the majority of countries, though testing requirements for Japan are currently much more extensive. 

Another important property which affects biocompatibility is permeability to low molecular weight solutes, since it is usually required that all extractable materials be leached from the device prior to use. These extractables include lower molecular weight species such as unreacted monomer, residual initiators,... 

It did not give rise to phase separation or precipitation. Similar behavior was observed when other types of polysaccharides were examined [53,54]. By now all the commercially important polysaccharides have been applied to the fabrication of hybrid silica nanocomposites in accordance with Scheme 3.2. What is more, various proteins have been entrapped in silica by the same means. In all instances the THEOS demonstrated good biocompatibility with biopolymers, even though its amount in formulations was sometimes up to 60 wt%. Biopolymer solutions after the precursor admixing remained homogeneous to the point of transition into a gel state. 

The main advantage is that the entrapment conditions are dictated by the entrapped enzymes, but not the process. This includes such important denaturing factors as the solution pH, the temperature and the organic solvent released in the course of precursor hydrolysis. The immobilization by THEOS is performed at a pH and temperature that are optimal for encapsulated biomaterial [55,56]. The jellification processes are accomplished by the separation of ethylene glycol that possesses improved biocompatibility in comparison with alcohols. 

---